Dyne Therapeutics, Inc
DYN
NASDAQ
Biotechnology
$25.70
USD
-0.26 (-1.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.85B
Volume 1.7M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
PBLS | Parabilis Medicines Inc | - | - | - | - | |
CAI | Caris Life Sciences Inc | $6.27B | 59.62 | +38.5% | - | |
PTCT | PTC Therapeutics Inc | $6.01B | - | -42.8% | - | |
TVTX | Travere Therapeutics Inc | $5.79B | - | +77.1% | - | |
ACAD | ACADIA Pharmaceuticals Inc | $4.89B | 12.85 | +47.0% | - | |
DYN | Dyne Therapeutics, Inc | $4.85B | - | - | - | |
RLAY | Relay Therapeutics Inc | $4.37B | - | +23.9% | - | |
CELC | Celcuity Inc | $4.36B | - | - | - | |
TNGX | Tango Therapeutics Inc | $4.33B | - | +39.0% | - |
Top Peer by Growth
Travere Therapeutics Inc
+77.1% YoY Revenue
Lowest P/E Ratio
ACADIA Pharmaceuticals Inc
12.85x P/E
Best 1-Year Return
Relay Therapeutics Inc
+499.1% Return